產(chǎn)品名稱:兔抗大鼠IgG(H+L)抗血清
英文名稱:Rabbit anti rat IgG (H+L) antiserum
規(guī)格及單位:1ml/10ml
產(chǎn)品型號(hào):YS-XQ0452
產(chǎn)地:進(jìn)口/國產(chǎn)
兔抗大鼠IgG(H+L)抗血清現(xiàn)貨供應(yīng),免費(fèi)快遞送貨上門,公司提供全程技術(shù)指導(dǎo),產(chǎn)品售前售中售后有保證,公司承諾:如有質(zhì)量問題無條件退換。
小鼠腦脊髓炎病毒(EV)抗體(IgG)ELISA Kit Mouse encephalomyelitis virus(EV)antibody(IgG)ELISA kit
小鼠腦啡肽原B(PDYN)ELISA Kit Mouse Proenkephalin-B,PDYN ELISA kit
小鼠腦啡肽原A(PENK)ELISA Kit Mouse proenkephalin A,PENK ELISA kit
保存方法:
(1)*保存的血清必須儲(chǔ)存于-20℃ - 70℃ 低溫冰箱中.4℃冰箱中保存時(shí)間切勿超過1個(gè)月.由于血清結(jié)冰時(shí)體積會(huì)增加約10%,因此,血清在凍入低溫冰箱前,必須預(yù)留一定體積空間,否則易發(fā)生污染或玻璃瓶凍裂.
(2)一般廠商提供的血清為無菌,無需再過濾除菌.如發(fā)現(xiàn)血清有懸浮物,則可將血清加入培養(yǎng)液內(nèi)一起過濾,切勿直接過濾血清.
(3)血清解凍: 瓶裝血清解凍需采用逐步解凍法:-20℃ 至 -70℃ 低溫冰箱中的血清放入4℃冰箱中溶解1天.然后移入室溫,待全部溶解后再分裝.在溶解過程中需不斷輕輕搖晃均勻(小心勿造成氣泡),使溫度與成分均一,減少沉淀的發(fā)生.切勿直接將血清從-20℃進(jìn)入37℃解凍,這樣因溫度改變太大,容易造成蛋白質(zhì)凝集而出現(xiàn)沉淀。
人抗心磷脂抗體IgG(ACA-IgG)免疫試劑盒 *直銷 英文名稱: Human anti-cardiolipin antibody IgG,ACA-IgG ELISA Kit
人抗心磷脂抗體IgA(ACA-IgA)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti-cardiolipin antibody IgA,ACA-IgA ELISA Kit
人抗心肌抗體(AMA)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human Anti-myocardial antibody,AMA ELISA Kit
人抗心肌β1受體(MB1R)自身抗體免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human myocardial β1 receptor (MB1R) autoantibody ELISA kit
人抗小鼠抗體(HAMA)免疫試劑盒 *直銷 英文名稱: Human anti-mouse antibody,HAMA ELISA kit
人抗小腦(CE)自身抗體免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti cerebellum (CE) autoantibody ELISA kit
人抗小核糖核蛋白/Sm(snRNP/Sm)抗體免疫試劑盒 進(jìn)口、分裝 英文名稱: Human small nuclear ribonucleoprotein(snRNP/Sm)antibody ELISA kit
人抗線粒體抗體M2亞型(AMA-M2)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human anti-mitochondrial antibody M2 subtype,AMA-M2 ELISA kit
人抗線粒體抗體(AMA)免疫試劑盒 *直銷 英文名稱: Human Anti-mitochondria autoantibodies,AMA ELISA Kit
人抗紋狀體(ST)自身抗體免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti striatum(ST)autoantibody ELISA kit
人抗胃壁細(xì)胞抗體(AGPA/PCA)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human anti-gastric parietal cell antibody,AGPA/PCA ELISA Kit
人抗尾狀核(CN)自身抗體免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human anti caudate nucleus(CN)autoantibody ELISA kit
人抗網(wǎng)硬蛋白抗體(ARA)免疫試劑盒 *直銷 英文名稱: Human anti-Reticulin antibody,ARA ELISA Kit
人抗外切酶體復(fù)合物成分RRP45(EXOSC9)抗體免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti exosome complex component RRP45(EXOSC9)antibody ELISA kit
人抗外切酶體成分10(EXOSC10)抗體免疫試劑盒 進(jìn)口、分裝 英文名稱: Human anti exosome component 10(EXOSC10)antibody ELISA kit
人抗唾液腺導(dǎo)管組織抗體(SDA)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human salivary duct autoantibody,SDA ELISA Kit
人抗脫氧核糖核蛋白抗體(DNP-Ab)免疫試劑盒 *直銷 英文名稱: Human deoxyribonucleic protein antibody,DNP-Ab ELISA Kit
人抗突觸前膜抗體(PsmAb)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti-presynaptic membrane antibody,PsmAb ELISA Kit
人抗突變型瓜氨酸波形蛋白抗體(anti-MCV Ab)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human anti-MCV Ab ELISA Kit
人抗透明帶抗體(aZP)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human anti-zona pellucida antibody,aZP ELISA Kit
人抗天然脫氧核糖核酸抗體(n-DNA-Ab)免疫試劑盒 *直銷 英文名稱: Human natural deoxyribonucleic acid antibody,n-DNA-Ab ELISA Kit
人抗糖蛋白抗體(GP)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti-glycoprotein antibody,GP ELISA Kit
人抗肽?;?脫亞胺酶4型(PADI4)抗體 免疫試劑盒 進(jìn)口、分裝 英文名稱: Human Protein-arginine deiminase type-4(PADI4)antibody ELISA Kit
人抗髓鞘少突膠質(zhì)細(xì)胞糖蛋白抗體(IgG)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human myelin oligodendrocyte glycoprotein antibody IgG ELISA Kit
人抗髓磷脂相關(guān)糖蛋白(MAG)抗體免疫試劑盒 *直銷 英文名稱: Human anti myelin-associated glycoprotein(MAG)antibody ELISA kit
人抗髓磷脂抗體IgA(anti-myelin Ab)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti-myelin antibody IgA ELISA Kit
人抗蘇氨?;鵷RNA合成酶,線粒體(TARS2)抗體免疫試劑盒 進(jìn)口、分裝 英文名稱: Human anti threonyl-tRNA synthetase, mitochondrial(TARS2)antibody ELISA kit
人抗蘇氨?;鵷RNA合成酶,細(xì)胞質(zhì)(TARS)抗體免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human anti threonyl-tRNA synthetase, cytoplasmic(TARS)antibody ELISA kit
人抗雙載蛋白(AMPH)抗體免疫試劑盒 *直銷 英文名稱: Human anti amphiphysin(AMPH)antibody ELISA kit
人抗雙鏈DNA抗體/天然DNA抗體(dsDNA)IgG免疫試劑盒 進(jìn)口、組裝 英文名稱: Human anti-double stranded DNA,dsDNA IgG ELISA KIT
人抗雙鏈DNA抗體/天然DNA(dsDNA)抗體(IgM)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human anti-double stranded DNA(dsDNA)antibody(IgM)ELISA Kit
人抗生長激素(GH)抗體免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human anti-growth hormone(GH)antibody ELISA Kit
人抗腎小球基底膜(GBM)抗體免疫試劑盒 *直銷 英文名稱: Human glomerular basement membrane(GBM)antibody ELISA kit
人抗腎小管基底膜抗體(TBM)免疫試劑盒 進(jìn)口、組裝 英文名稱: Human tubular basement membrane antibogy,TBM ELISA Kit
人抗腎上腺皮質(zhì)抗體(AAA)免疫試劑盒 進(jìn)口、分裝 英文名稱: Human Anti-adrenocortical antibody,AAA ELISA Kit
人抗神經(jīng)元核抗體2型/抗Ri抗體(ANNA-2/Ri)免疫試劑盒 現(xiàn)貨供應(yīng) 英文名稱: Human neuronal nuclear autoantibody,ANNA-2/Ri ELISA Kit
PP2 (1 mg) 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; AGL 1879; PP2
PP2 (10 mg) 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; AGL 1879; PP2
PP2 (25 mg) 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; AGL 1879; PP2
PP2 (5 mg) 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; AGL 1879; PP2
cis-trismethoxy Resveratrol (10 mg) 1,3-dimethoxy-5-[(1Z)-2-(4-methoxyphenyl)ethenyl]-benzene; cis-Trimethoxy Stilbene; cis-trismethoxy Resveratrol
cis-trismethoxy Resveratrol (100 mg) 1,3-dimethoxy-5-[(1Z)-2-(4-methoxyphenyl)ethenyl]-benzene; cis-Trimethoxy Stilbene; cis-trismethoxy Resveratrol
cis-trismethoxy Resveratrol (50 mg) 1,3-dimethoxy-5-[(1Z)-2-(4-methoxyphenyl)ethenyl]-benzene; cis-Trimethoxy Stilbene; cis-trismethoxy Resveratrol
cis-trismethoxy Resveratrol (500 mg) 1,3-dimethoxy-5-[(1Z)-2-(4-methoxyphenyl)ethenyl]-benzene; cis-Trimethoxy Stilbene; cis-trismethoxy Resveratrol
G-418 Sulfate (1 g) O-2-amino-2,7-dideoxy-D-glycero-α-D-gluco-heptopyranosyl-(1→4)-O-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)]-2-deoxy-sulfate-D-streptamine; Geneticin; G-418 Sulfate
Daidzin (10 mg) 7-(β-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Daidzoside| NPI 031D; Daidzin
Daidzin (100 mg) 7-(β-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Daidzoside| NPI 031D; Daidzin
Daidzin (5 mg) 7-(β-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Daidzoside| NPI 031D; Daidzin
Daidzin (50 mg) 7-(β-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Daidzoside| NPI 031D; Daidzin
Halopemide (1 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide; NSC 354856|R34301; Halopemide
Halopemide (10 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide; NSC 354856|R34301; Halopemide
Halopemide (25 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide; NSC 354856|R34301; Halopemide
Halopemide (5 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide; NSC 354856|R34301; Halopemide
VU0155069 (1 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-naphthalenecarboxamide; CAY10593; VU0155069
VU0155069 (10 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-naphthalenecarboxamide; CAY10593; VU0155069
VU0155069 (25 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-naphthalenecarboxamide; CAY10593; VU0155069
VU0155069 (5 mg) N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-naphthalenecarboxamide; CAY10593; VU0155069
CAY10594 (1 mg) N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]dec-8-yl)ethyl]-2-naphthalenecarboxamide; CAY10594
CAY10594 (10 mg) N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]dec-8-yl)ethyl]-2-naphthalenecarboxamide; CAY10594
CAY10594 (25 mg) N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]dec-8-yl)ethyl]-2-naphthalenecarboxamide; CAY10594
CAY10594 (5 mg) N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]dec-8-yl)ethyl]-2-naphthalenecarboxamide; CAY10594
Mirin (10 mg) 2-amino-5-[(4-hydroxyphenyl)methylene]-4(5H)-thiazolone; Mirin
Mirin (100 mg) 2-amino-5-[(4-hydroxyphenyl)methylene]-4(5H)-thiazolone; Mirin
Mirin (5 mg) 2-amino-5-[(4-hydroxyphenyl)methylene]-4(5H)-thiazolone; Mirin
Mirin (50 mg) 2-amino-5-[(4-hydroxyphenyl)methylene]-4(5H)-thiazolone; Mirin
N-octadecanoyl-L-Homoserine lactone (10 mg) N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octadec*; C18-HSL; N-octadecanoyl-L-Homoserine lactone
N-octadecanoyl-L-Homoserine lactone (25 mg) N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octadec*; C18-HSL; N-octadecanoyl-L-Homoserine lactone
N-octadecanoyl-L-Homoserine lactone (5 mg) N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octadec*; C18-HSL; N-octadecanoyl-L-Homoserine lactone
N-octadecanoyl-L-Homoserine lactone (50 mg) N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octadec*; C18-HSL; N-octadecanoyl-L-Homoserine lactone
Pimelic Diphenylamide 106 (1 mg) N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide; TC-H 106|Histone Deacetylase Inhibitor VII; Pimelic Diphenylamide 106
Pimelic Diphenylamide 106 (10 mg) N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide; TC-H 106|Histone Deacetylase Inhibitor VII; Pimelic Diphenylamide 106
Pimelic Diphenylamide 106 (25 mg) N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide; TC-H 106|Histone Deacetylase Inhibitor VII; Pimelic Diphenylamide 106
Pimelic Diphenylamide 106 (5 mg) N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide; TC-H 106|Histone Deacetylase Inhibitor VII; Pimelic Diphenylamide 106
N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone (1 mg) 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-7-tetradecenamide; 3-oxo-C14:1-Δ7cis-(L)-HSL; N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone
N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone (10 mg) 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-7-tetradecenamide; 3-oxo-C14:1-Δ7cis-(L)-HSL; N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone
N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone (25 mg) 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-7-tetradecenamide; 3-oxo-C14:1-Δ7cis-(L)-HSL; N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone